Skip to main content

Month: November 2022

Vallourec wins major Line-Pipe order from ExxonMobil Guyana

                  Vallourec wins major Line-Pipe order from ExxonMobil Guyana Meudon, France, 30 November 2022 – Vallourec has secured a third major order in the framework of the Long-Term Agreement (LTA) signed last year with ExxonMobil Guyana. Under the contract, Vallourec will deliver line-pipe for ExxonMobil Guyana’s deep-water Uaru project. The Uaru project is located in the Stabroek Block, a 26,800 km2 strategic basin located off Guyana’s continental shelf, where several important discoveries have been made since 2015. The Group will deliver 35,000 metric tons of line-pipe, including 2,000 metric tons of X80, an innovative and unique material developed and qualified by Vallourec’s R&D teams. The X80 combines high strength with resistance to service conditions, making it a key enabler for future deeper-water developments....

Continue reading

BelCosta Labs and U.S. Cannalytics Merge in Key East Coast Cannabis Markets

Leading Cannabis Testing Labs From East and West Coast Markets Unify Brands as BelCosta Labs LONG BEACH, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — BelCosta Labs, a leading California third-party cannabis testing lab, today announced the company is expanding its operations beyond California. BelCosta is combining businesses with independent testing labs US Cannalytics (“USC”) and Pinnacle CT Labs (“PCT”). USC currently services Florida, New Jersey, and Pennsylvania, and PCT services Maryland. All laboratories will be rebranded and operate as BelCosta Labs. The merger combines over ten years of cannabis-specific, analytical testing expertise from five different state markets to create a national laboratory group rooted in quality, transparency, and innovation. The new lab group is positioned to lead the evolution of the cannabis testing...

Continue reading

Lottery.com Receives Expected Notice from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q

AUSTIN, Texas, Nov. 30, 2022 (GLOBE NEWSWIRE) — As previously disclosed in the Lottery.com Inc. (the “Company”) Notification of Late Filing on Form 12b-25, filed with the Securities and Exchange Commission (the “SEC”) on August 16, 2022, the Company has not yet finalized its review of its financial statements or its assessment of the impact of the findings of the ongoing review of the Company’s internal accounting controls on its historical financial statements or for the financial statements for the quarters ended June 30, 2022 or September 30, 2022, and is therefore unable to file its Quarterly Reports on Form 10-Q for the periods ended June 30, 2022 or September 30, 2022. On November 28, 2022, the Company received a notice (the “Notice”), dated November 16, 2022, from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as...

Continue reading

Rovio Entertainment Corporation: Repurchase of own shares on 30 November 2022

Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 30.11.2022 at 18.45 EET   Rovio Entertainment Corporation – Repurchase of own shares on 30.11.2022   Rovio Entertainment Corporation  In the Nasdaq Helsinki  Date 30.11.2022Exchange transaction BUYShare trading code ROVIOAmount, shares 35000Average price/share, EUR 5,942189Total cost, EUR 207976,60      Rovio now holds a total of 6 417 613 shares including the shares repurchased on 30.11.2022   On behalf of Rovio Entertainment Corporation     OP Corporate Bank PLC  Further information:Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution:Nasdaq Helsinki LtdKey mediawww.rovio.com About Rovio:Rovio Entertainment Corporation is a global mobile-first games company that creates,...

Continue reading

AKWEL: 2023 FINANCIAL COMMUNICATION CALENDAR

        30 November 2022 at 5:45 pm 2023 FINANCIAL COMMUNICATION CALENDAR AKWEL (FR0000053027, AKW, PEA), an automotive and HGV equipment and systems manufacturer specialising in fluid management and mechanisms, announced its financial communication calendar for 2023:  Press releases MeetingsFull-year 2022 revenue Thursday 09 February 2023  Full-year 2022 results Thursday 6 April 2023 Friday 7 April 2023First-quarter 2023 revenue Thursday 4 May 2023  Annual General Meeting Thursday 25 May 2023  First half-year 2023 revenue Thursday 27 July 2023  First half-year 2023 results Thursday 21 September 2023 Friday 22 September 2023Third-quarter 2023 revenue Thursday 09 November 2023  All aforementioned press statements will be disclosed after closing of usual trading day. Calendar may be subject to change and is communicated...

Continue reading

Revenue of AB Linas Agro Group for the three months of the 2022/2023 financial year grows by one third

The consolidated revenue of the companies managed by AB Linas Agro Group (or the Group) for the three months of the financial year 2022/2023 exceeded EUR 590 million and was 34% higher than in the previous year (EUR 440 million). The Group sold 951 thousand tons of various products, or 8% less than in the same period of the last year (1,030 thousand tons). Consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) amounted to almost EUR 46 million, 92% higher than in the previous year (EUR 24 million). Net profit increased by 144% to over EUR 28 million.  3 monthsof FY2021/22 3 monthsof FY2022/23 Change 2022/23 compared to2021/22, %Gross profit, TEUR 37 595 56 059 49EBITDA, TEUR 23 793 45 661 92Operating profit (loss), TEUR 19 659 43 809 123Profit before tax, TEUR 14 577 38 176 162Net profit...

Continue reading

FL Entertainment: 9M 2022 results

Press Release Paris – November 30th, 2022 9M 2022 RESULTS STRONG REVENUE GROWTH,HIGH PROFITABILITY AND CASH FLOW CONVERSION 9M 2022 FIGURESRevenue growth: €2,713m, up +15.0% on a reported basis and +12.0% at constant exchange rates Adjusted EBITDA1: €446m, up +17.5% versus 9M 2021, leading to 40bp margin increase to 16.5% Adjusted net income: €210m up +15.4% versus €182m for the first 9M 2021 Net income: -€75m (9M 2021: -€2m) due to one-off impact from Group re-organization and listing Adjusted free cash flow1: €369m, representing a cash flow conversion of 83% Net financial debt / Adj. EBITDA2 ratio: improved to 3.4x as of September 30, 2022 versus 3.7x as at December 31, 2021, in line with 2022 guidance9M 2022 HIGHLIGHTSContent production & distributionRevenue up +13.8%3 with a return to normalized pre-covid seasonality in...

Continue reading

Management change at ALK

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that Søren Jelert, Executive Vice President, CFO and member of the Board of Management, has decided to resign his position to join a company in another sector and will expectedly leave ALK on 31 May 2023. Chairman of the Board of Directors, Anders Hedegaard, and President & CEO, Carsten Hellmann said: “We would like to offer our sincere thanks to Søren for his pivotal role in ALK’s transformation over the past five years. We wish him the best of luck in his future career.” A search for a new CFO has been initiated. ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Media: Jeppe Ilkjær, mobile +45 3050 2014 This information is information that ALK-Abelló A/S is obliged to make public...

Continue reading

IGC to Present at the RHK 2022 Disruptive Growth Conference

POTOMAC, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) — India Globalization Capital, Inc (NYSE American: IGC) (“IGC” or the “Company”) today announced that Ram Mukunda, Chief Executive Officer, will be presenting at the RHK Disruptive Growth Conference in New York City on Monday, December 5 at 11:20 am ET and will be available for one-on-one meetings on Monday, December 5 and Tuesday, December 6. About IGC India Globalization Capital Inc. develops advanced cannabinoid-based formulations for treating diseases, including but not limited to Alzheimer’s disease, Parkinson’s disease, chronic pain, and pet seizures. The Company’s leading drug candidate, IGC-AD1, has demonstrated, in Alzheimer’s cell lines, the potential to be effective in suppressing or ameliorating a key protein responsible for Aβ plaques and has recently entered Phase 2 clinical...

Continue reading

XCPCNL Business Services announces that it has been hired by Black Bird Biotech to Boost Bee Tested, Bee Safe MiteXstream Biopesticide Sales Within Cannabis Industry

Charlotte, North Carolina, Nov. 30, 2022 (GLOBE NEWSWIRE) — XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in the consumer products industry, today announced that it has been hired by Black Bird Biotech, Inc. (OTC: BBBT) manufacturer and distributor of plant-based MiteXstreamTM biopesticide to provide brand awareness and direct sales expertise for MiteXstreamTM specifically as it relates to B2B sales within the Cannabis Industry. “We are incredibly excited to work with BBBT and believe that we will be successful in promoting the special qualities of MiteXstreamTM to the many verticals within the Cannabis Industry. Creating and growing product awareness in market segments for our clients’ brands is XCPCNL’s sweet spot.” said XCPCNL CEO Tim Matthews....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.